Terazosin Hydrochloride
- Description
- Clinical Pharmacology
- Indications & Usage
- Contraindications
- Warnings
- Precautions
- Side Effects
- Overdosage
- Dosage & Administration
- How Supplied
- Patient Counseling Information
- Supplemental Patient Material
- Boxed Warning
- Patient Package Insert
FULL PRESCRIBING INFORMATION: CONTENTS*
- DESCRIPTION
- CLINICAL PHARMACOLOGY
- INDICATIONS & USAGE
- CONTRAINDICATIONS
- WARNINGS
- PRECAUTIONS
- INFORMATION FOR PATIENTS
- DRUG INTERACTIONS
- CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
- PREGNANCY
- NURSING MOTHERS
- PEDIATRIC USE
- ADVERSE REACTIONS
- OVERDOSAGE
- DOSAGE & ADMINISTRATION
- HOW SUPPLIED
- STORAGE AND HANDLING
- SPL PATIENT PACKAGE INSERT
- PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
FULL PRESCRIBING INFORMATION
DESCRIPTION

CLINICAL PHARMACOLOGY
Pharmacodynamics-
● p
-
● FIGURE 3. Mean Change in Peak Flow Rate from Baseline Long-Term, Open-Label, Non-Placebo Controlled Study (N=494)
Pharmacokinetics
INDICATIONS & USAGE
CONTRAINDICATIONS
WARNINGS
PRECAUTIONS
GeneralINFORMATION FOR PATIENTS
DRUG INTERACTIONS
Use With Other Drugs
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
PREGNANCY
NURSING MOTHERS
PEDIATRIC USE
ADVERSE REACTIONS
Benign Prostatic HyperplasiaHypertension
Post-marketing Experience
OVERDOSAGE
DOSAGE & ADMINISTRATION
Benign Prostatic Hyperplasia
Hypertension
HOW SUPPLIED
STORAGE AND HANDLING
SPL PATIENT PACKAGE INSERT
LABORATORY TESTS
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION



Terazosin HydrochlorideTerazosin Hydrochloride CAPSULE
|
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!